Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glycopyrrolate (25mcg) Respule
Therapeutic Category
Pulmonary, Respiratory
Dosage Form
Respule
Packaging Type
Pack
Packaging
4*5*2ml
Price
₹350/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Glycopryl 25 Respule is a prescription medication containing Glycopyrrolate, a long-acting anticholinergic agent used primarily in the treatment of respiratory conditions. Glycopyrrolate works by blocking the action of acetylcholine, a neurotransmitter that stimulates the contraction of smooth muscles in the lungs. By inhibiting acetylcholine, Glycopryl helps to relax the muscles around the airways, resulting in improved airflow and easier breathing.
This medication is commonly used in the management of chronic obstructive pulmonary disease (COPD) and can be used in combination with other respiratory treatments to improve lung function. Glycopryl 25 Respule is intended for use with a nebulizer, which transforms the liquid solution into a fine mist, allowing it to be inhaled directly into the lungs. This ensures rapid and efficient delivery of the medication to the airways.
Glycopryl 25 Respule is beneficial for those experiencing persistent airway constriction and helps to reduce the frequency of exacerbations associated with COPD. It can also be used for other conditions as directed by a healthcare provider.
Possible side effects include dry mouth, sore throat, cough, or a mild headache. In rare cases, it may cause blurred vision or urinary retention.
Glycopryl 25 Respule is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and for reducing bronchospasm in respiratory conditions.
Not for use during acute asthma attacks. Follow the prescribed dosage and consult a healthcare provider if symptoms persist.
Store at room temperature, away from moisture, heat, and sunlight. Keep the vial tightly closed and out of the reach of children.
Composition : Glycopyrrolate IP 50mcg Rota Capsule
Composition : Glycopyrronium (25mcg) + Formoterol (12mcg)+ Budesonide (400 mcg) Rota Capsule
Composition : Budesonide (0.5mg) Respule
Composition : Budesonide (200mcg) + Formoterol (6mcg) Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (20mcg) + Budesonide (0.5mg) Respule
Composition : Levosalbutamol (1.25mg) + Budesonide (0.5mg) Respule
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Glycopyrrolate 25 mcg Respule has strong demand in the respiratory and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on COPD, asthma, and hospital nebulization therapy portfolios.
Medical distributors and agencies can benefit from consistent demand for bronchodilation therapy in COPD and severe respiratory conditions requiring nebulization support. Glycopyrrolate is a long-acting muscarinic antagonist (LAMA) that helps relax airway muscles and improve airflow Used in hospital, emergency, and respiratory care settings via nebulization therapy This strengthens a reliable respiratory-care injectable/nebulization portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Glycopyrrolate Respule with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong pulmonologist prescriptions, hospital demand, critical-care usage, chronic COPD patient management, reliable supply chain support, and good margins in respiratory medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.